HOME >> BIOLOGY >> NEWS
Scientists discover molecular target for treatment of T cell acute lymphoblastic leukemia

A new research study published in the June issue of Cancer Cell identifies the molecular events that contribute to a notoriously treatment-resistant form of T cell leukemia.

The findings reveal that disruption of immune cell differentiation is central to disease progression and provide new avenues for development of future therapeutics.

T cell acute lymphoblastic leukemia (T-ALL) accounts for 10%-15% of pediatric and 25% of adult ALL cases. A gene called TAL1/SCL is frequently activated in T-ALL patients, but exactly how it causes leukemia has not been clear.

Dr. Michelle Kelliher, from the Department of Cancer Biology at the University of Massachusetts Medical School in Worcester, Massachusetts, and colleagues examined how the TAL1/SCL protein contributes to leukemia.

The researchers demonstrate that TAL1/SCL induces leukemia by interfering with a protein called E47/HEB that regulates the expression of many different genes required for immune cell differentiation and survival.

When these genes were experimentally inhibited by TAL1/SC1 in mice, the mice exhibited abnormal immune (T cell) development, and most eventually developed leukemia.

The researchers also showed that TAL1/SCL silences gene expression by recruiting a histone deacetylase (HDAC) repressor complex, and in fact, HDAC inhibitors were very effective at inhibiting the growth of TAL1/SCL tumor cells.

"Our work demonstrates that TAL1/SCL induces leukemia by repressing E47/HEB activity, and suggests that HDAC inhibitors may prove efficacious in T-ALL patients who express TAL1/SCL. This is an important discovery, as these particular patients respond poorly to current chemotherapies and are at high risk for treatment failure," says Dr. Kelliher.


'"/>

Contact: Heidi Hardman
hhardman@cell.com
617-397-2879
Cell Press
14-Jun-2004


Page: 1

Related biology news :

1. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
2. Scientists sequence genome of kind of organism central to biospheres carbon cycle
3. Scientists find nanowires capable of detecting individual viruses
4. Scientists discover potential new way to control drug-resistant bacteria
5. Scientists explore genome of methane-breathing microbe
6. Scientists decipher genetic code of biothreat pathogen
7. Stuck on you: Scientists lay bare secrets of bacterial attachment proteins
8. Scientists discover proteins involved in spread of HIV-1 infection
9. Scientists fear new Ebola outbreak may explain sudden gorilla disappearance
10. Scientists reinvent DNA as template to produce organic molecules
11. Scientists visualise cellular handmaiden that restores shape to proteins

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2019)... Md. (PRWEB) , ... March 29, 2019 , ... ... Stem/Stromal Cell (hMSC) biomanufacturing systems, will attend the Society for Biomaterials Annual Meeting ... gives us the opportunity to connect with academic, healthcare, governmental and business professionals ...
(Date:3/27/2019)... ... March 27, 2019 , ... ... been awarded the 2019 Global Health & Pharma Biotechnology Award as the Best ... & Pharma’s Biotechnology Awards honor individuals and companies whose accomplishments have proved evidence ...
(Date:3/25/2019)... ... March 25, 2019 , ... ... and research genetic testing, today announced a new laboratory services agreement with Clovis ... for cancer. Through this laboratory services agreement, Ambry Genetics and Clovis Oncology ...
Breaking Biology News(10 mins):
(Date:4/8/2019)... ... , ... US Capital Global Securities , an affiliate of US Capital ... privately held pharmaceutical company, S1 Biopharma (“S1”). , S1 has a pipeline of drugs ... dysfunction disorder and is ready to begin phase 2b trials. In phase 2a trials, ...
(Date:3/27/2019)... ... March 26, 2019 , ... A leader in the field ... to veterinarians across the United States and Canada since 2004. The primary indications ... tissue injuries in the dog, cat, and horse. Recently, VetStem teamed up ...
(Date:3/19/2019)... ... , ... The AACR annual conference pulls together a diverse group of clinical ... research. The Visikol team will be at the show at booth #3252 and will ... their digital pathology services . “For AACR this year we are highlighting specifically ...
(Date:3/19/2019)... BASEL, Switzerland (PRWEB) , ... ... ... Center at Tel HaShomer, the largest hospital in Israel and the Middle ... cell-therapy manufacturing using the state-of-the-art Cocoon™ manufacturing platform. The partnership will enable ...
Breaking Biology Technology:
Cached News: